Biospace was kind enough to sit with Mispro's Keith Astrofsky and Yohan Tessier to discuss how the contract vivarium enables researchers to keep their preclinical studies in-house and the many benefits this capability offers them. Read the story here
We are pleased to announce the appointments of Keith Astrofsky, DVM, to Vice President of of Operations & Capital Asset Development and Yohan Tessier, BSc EMBA MBA to Vice President of Commercial Operations & Strategic Development at Mispro Biotech Services.Dr. Astrofsky's leadership has been defining & inspiring in Mispro’s commitment to being the very best in what we do – which…
Congratulations to Mispro's Mark Snead, BS, RALAT, for taking home the PMI LabDiet Award for Laboratory Animal Technician of the Year at the 2019-2020 RTB AALAS awards banquet!
Today, we announced the opening of our brand new, state-of-the-art, premium #vivariumspace in the biotech supercluster, South San Francisco. This location is the perfect place to launch, expand, and scale early-stage #invivo studies. The campus will also offer an in vitro lab incubator adjacent to our facility – providing a comprehensive offering for all preclinical development needs in a single…
Mispro Biotech Services is excited to announce that we will be participating in multiple events at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, taking place from January 12-16, 2020. Our CEO, Philippe Lamarre, will be part of an esteemed panel of Biotech & Pharma leaders for a discussion on Enhancing the R&D Landscape: Optimizing the Path to Development.…